Entities / Company
Janssen.
company in Cologno Monzese, Italy
- Reports this week
- 0
- Active events
- 0
- Connections
- 14
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
Gone quiet
No new reports in 90+ days-
Genmab, a Denmark-based biotechnology company headquartered in Copenhagen, partnered with Janssen for commercialization.Some support1 report
-
AC Immune announced details regarding ongoing collaborations with Janssen and LILLY, led by CEO Andrea Pfeifer.Some support3 reports
-
GSK, Janssen, and Meiji Seika Pharma were all featured in the NTM therapeutics market report on July 17, 2025.Some support1 report
-
Janssen received EC approval for DARZALEX Faspro co-formulated with ENHANZE.Some support1 report
-
Lunai Bioworks, formerly Renovaro Inc., announced a company name change and confirmed the inheritance of key collaborations with Janssen and Merck KGaA.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Janssen this week
News at the entities that move Janssen most-
Genmab TransactionalCorbus Pharmaceuticals discussed Genmab's results concerning head and neck cancer.Moves Janssen
-
Eli Lilly and Company OperationalMastercard, Eli Lilly, and Visa are noted as holdings within the Vanguard Morningstar Growth ETF (VUG).Moves Janssen
-
Medicare Shared contextAnthropic seeks Nasdaq listing, OpenAI agent accessed Medicare, and Albanese government tightens AI oversight.Moves Janssen
Connections
The 5 strongest of 14, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Genmab Transactional
Genmab and Janssen have entered into a partnership regarding the commercialization of the product daratumumab.
-
Halozyme Therapeutics Structural
Halozyme licenses its ENHANZE technology to Janssen, which uses it to co-formulate pharmaceutical products.
-
Legend Biotech Operational
The relationship is defined by a collaboration agreement that drives higher sales for Legend Biotech.
-
Eli Lilly and Company Operational
Both companies compete in the immuno-oncology therapeutic space.
-
Medicare Shared context
Janssen's drugs are utilized within the Medicare healthcare program.
History
Events by the month they beganSeptember 2026
1 eventJune 2026
5 events- Genmab, a Denmark-based biotechnology company headquartered in Copenhagen, partnered with Janssen for commercialization.
- AC Immune announced details regarding ongoing collaborations with Janssen and LILLY, led by CEO Andrea Pfeifer.
- GSK, Janssen, and Meiji Seika Pharma were all featured in the NTM therapeutics market report on July 17, 2025.
- Janssen received EC approval for DARZALEX Faspro co-formulated with ENHANZE.
- Lunai Bioworks, formerly Renovaro Inc., announced a company name change and confirmed the inheritance of key collaborations with Janssen and Merck KGaA.